SYNE3 and urinary bladder carcinoma: To elucidate the possible influences of LINC00341 on bladder cancer, we assessed the changes in cell proliferation, apoptosis, as well as motility induced by LINC00341 silencing by CRISPR-CasRx in bladder cancer.